Beriberi is a disease caused by thiamine deficiency resulting in peripheral neuropathy and myocardial dysfunction. Increases in vascular endothelial growth factor (VEGF) are seen in polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes, called POEMS syndrome. We present herein two cases of wet beriberi accompanied by a moderate increase in VEGF level. Serum VEGF decreased after treatment in both cases. Our experience with these cases suggests that beriberi should be considered in the differential diagnosis of polyneuropathy with a moderate increase in serum VEGF, and that the serum VEGF level may be a therapeutic marker for beriberi.
Introduction
Beriberi is a disease caused by thiamine (vitamin B1) deficiency (1) . Beriberi has three forms: dry beriberi, wet beriberi (shoshin beriberi), and infantile beriberi (1, 2) . Dry beriberi is characterized by a sensorimotor, distal, axonal peripheral neuropathy often associated with calf cramps, muscle tenderness, and burning feet. Wet beriberi is associated with high-output heart failure with peripheral neuropathy. The terms wet and dry beriberi have been used to describe the presence or absence of edema in neuropathic beriberi (2) .
Vascular endothelial growth factor (VEGF), which acts as a potent inducer of blood vessel formation in early development, plays a central role in the growth of new blood vessels (3) . Increases in VEGF level are seen in a rare multisystem disease generally associated with polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes, called POEMS syndrome (POEMS) (4). Peripheral edema is often associated with POEMS (5) . Few studies have demonstrated an increased VEGF level in other polyneuropathies (6) (7) (8) . To the best of our knowledge, there has been only one previous report of beriberi with elevated serum VEGF (9) . Here, we report two cases of wet beriberi with an accompanying increase in VEGF level.
Case Reports

Case 1
A 49-year-old man was admitted to his local orthopaedic hospital with an 8-day history of progressive weakness and paraesthesia. His weakness and paraesthesia initially affected his lower limbs, progressing within 4 days to his upper limbs. For 3 days prior to the onset of his symptoms he developed a fever rising to 38 . No history of exposure to toxins or family history of neuropathy was apparent. The admitting orthopaedist at the local orthopaedic hospital found no abnormal findings on spinal MRI and transferred the patient to our hospital. On examination his height was 166 cm, weight was 72.0 kg, body temperature was 36.9 , heart rate was 72 BPM and blood pressure was 158/92 mmHg. Hepatosplenomegaly, lymphadenopathy, hypertrichosis and edema of the lower limbs were not seen. Neurological examination revealed moderate muscle weakness and mild sensory disturbance of both upper and lower limbs. Deep tendon reflexes were absent in all extremities. Labora- tory data revealed elevated total bilirubin (1.7 mg/dL), γ-glutamyl transpeptidase (381 IU/L) and serum VEGF level (1,050 pg/mL; normal: >200 pg/mL). Serum M protein was negative. Cerebrospinal fluid study was normal. A nerve conduction study revealed decreases in sensory and motor nerve conduction velocity in the lower limbs (Table 1) . Weakness and paraesthesia continued to progress after admission, but the patient was discharged at his request. Twelve days after leaving the hospital, he was readmitted for anasarca and high-output heart failure. At readmission he confessed to being a heavy drinker. Serum vitamin B1 demonstrated below normal values (11 ng/mL). High-potency intravenous multivitamins containing 100 mg of thiamine, 100 mg of pyridoxine and 1 mg of cyanocobalamin were commenced shortly after readmission, and then oral thiamine (100 mg twice a day) was administered. Within 2 weeks of treatment, anasarca and congestive heart failure disappeared. He was discharged 4 weeks after readmission. Moderate weakness and mild paraesthesia improved to mild weakness and slight paraesthesia, and serum VEGF level was decreased (728 pg/mL) at discharge.
Case 2
A 70-year-old man was admitted to our hospital with a 6-year history of progressive paraesthesia affecting his extremities and a 1-month history of edema affecting his lower limbs. He drank 100 mL of a rice-based alcoholic beverage (sake) every day and ate mainly polished rice (rice from which the thiamine-rich mantle has been scraped off). No history of exposure to toxins or family history of neuropathy was apparent. On examination his height was 160 cm, his weight was 60.2 kg, body temperature was 36.0 , heart rate was 75 BPM and blood pressure was 87/58 mmHg. Physical examination revealed ejection systolic murmur and severe edema of the lower limbs. Hepatosplenomegaly, lymphadenopathy, and hypertrichosis were not seen. Neurological examination revealed stupor, moderate muscle weakness and moderate sensory disturbance of the lower limbs. Deep tendon reflexes were absent in all extremities. Laboratory data revealed anaemia, hyponatremia (112.2 mEq/L), elevated serum VEGF (598 pg/mL) and a below normal level of serum vitamin B1 (6 ng/mL). Brain MRI revealed no abnormal findings. A nerve conduction study revealed decreases in sensory and motor nerve conduction velocity in the lower limbs (Table 1) . Echocardiogram showed highoutput heart failure. High potency intravenous multivitamins and then oral thiamine (75 mg three times a day) were commenced. Within 2 weeks of treatment, edema, stupor and hyponatremia disappeared. He was discharged 6 weeks after admission. Moderate weakness and moderate paraesthesia improved to mild weakness and mild paraesthesia, and serum VEGF level was normalized (47 pg/mL) at discharge.
Discussion
Beriberi is not typically described as presenting with elevated serum VEGF, with the exception of the case described by Nakagawa et al. (9) . Their case, a 66-year-old man, had a low level of serum vitamin B1 (19 ng/mL) and a high level of serum VEGF (890 pg/mL). Sural nerve biopsy demonstrated severe axonal degeneration without inflammatory change and mild subperineurial edema. The clinical features of their case as well as the present two cases are shown in Table 2 . All cases were men with wet beriberi. The cause of the vitamin B1 deficiency was different among the three cases, including gastrectomy, chronic alcoholism and food faddism. Two cases were acute onset and one case was chronic. All cases showed primarily axonal damage on electromyogram. The levels of serum VEGF in all cases decreased or normalized after vitamin B1 replacement.
The mean level of serum VEGF in these three patients with beriberi was 846.0±229.2 pg/mL. The level of serum VEGF in POEMS has been reported to be about 15-30 times greater [1,673±1,165.7 pg/mL (mean ± SD)] than control subjects (3). Our previous study found levels of serum VEGF in POEMS to be even higher, at 3,852.2±1,612.3 pg/ mL (10). The mean plasma VEGF level in patients with vasculitic neuropathy was reported to be 303±182 pg/mL and the plasma VEGF level in almost all cases was below 500 pg/mL (6). The mean serum VEGF level in patients with diabetic polyneuropathy was reported to be 310.1±224.3 pg/ mL and plasma VEGF level in some cases of diabetic polyneuropathy demonstrated a level of about 1,000 pg/mL (7). These results suggest that a moderate increase of serum VEGF level might help distinguish beriberi from vasculitic neuropathy. Polyneuropathy with POEMS is mainly the demyelinating type, whereas polyneuropathy with beriberi is mainly the axonal type. The difference in the type of peripheral neuropathy between POEMS and beriberi might be related to the mechanism of elevation of serum VEGF. Increased serum VEGF in POEMS is thought to be due to secretion from plasma cells in bone lesions and/or systemic circulation (4). The consequential reduction of oxygen supply with the endothelial injury caused by an abnormal activation of endothelial cells by VEGF induces a secondary increase in local VEGF expression (11) . Mild elevation of serum VEGF with diabetic polyneuropathy may occur. It is hypothesised that VEGF production is stimulated by hyperglycemia and hypoxia as a survival factor for neuroprotection (6) . As neither plasma cells nor hyperglycemia was demonstrated in these beriberi patients, the mechanism of serum VEGF elevation with beriberi is hypothesised to be due to hypoxia from endothelial injury. The presence of subperineurial edema seems to support the presence of endothelial injury, and high-output heart failure may worsen hypoxemia.
The level of serum VEGF in POEMS decreased after treatment in our cases, and the level of serum VEGF is suggested to be a treatment marker for POEMS (4) . Our study demonstrated that serum VEGF level could also be a therapeutic marker of clinical findings such as neuropathy and heart failure for beriberi.
The major limitation of our study was the limited number of patients, resulting in the presentation of case reports. In addition serum VEGF levels for dry beriberi remain unknown because only wet beriberi cases have been reported. Considering these limitations, wet beriberi may be considered in the differential diagnosis of polyneuropathy with edema and a moderate increase in serum VEGF.
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